| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.960 | 67.746 | 76.447 | 57.040 | 52.137 | 55.073 | 84.184 | 89.852 | 105.726 | 97.889 |
| Total Income - EUR | 42.037 | 67.804 | 77.259 | 57.138 | 52.284 | 55.073 | 84.190 | 89.852 | 116.283 | 97.889 |
| Total Expenses - EUR | 5.083 | 4.497 | 12.801 | 15.863 | 15.228 | 13.065 | 18.603 | 8.692 | 17.743 | 24.523 |
| Gross Profit/Loss - EUR | 36.954 | 63.308 | 64.459 | 41.276 | 37.056 | 42.009 | 65.587 | 81.159 | 98.540 | 73.366 |
| Net Profit/Loss - EUR | 35.693 | 61.275 | 62.142 | 39.314 | 35.492 | 40.357 | 63.062 | 78.464 | 95.368 | 70.430 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 |
Check the financial reports for the company - Mihaltan Med Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.298 | 14.919 | 54.768 | 44.586 | 34.935 | 25.651 | 16.653 | 13.181 | 67.001 | 55.149 |
| Current Assets | 22.762 | 49.268 | 9.263 | 18.690 | 9.585 | 16.466 | 48.630 | 67.688 | 29.256 | 14.421 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.352 | 3.676 | 5.808 | 7.015 | 5.120 | 7.166 | 19.193 | 5.638 | 9.722 | 8.111 |
| Cash | 3.662 | 33.345 | 3.455 | 11.676 | 4.465 | 9.300 | 29.437 | 62.050 | 19.534 | 6.310 |
| Shareholders Funds | 35.747 | 61.329 | 62.195 | 57.389 | 42.486 | 40.406 | 63.110 | 78.512 | 95.417 | 70.478 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.314 | 2.858 | 1.836 | 5.887 | 2.034 | 1.711 | 2.172 | 2.356 | 2.825 | 1.066 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mihaltan Med Consult Srl